Wnt/β-Catenin Signaling Contributes to Skeletal Myopathy in Heart Failure via Direct Interaction With Forkhead Box O
Katsuki Okada, MD; Atsuhiko T. Naito, MD, PhD; Tomoaki Higo, MD; Akito Nakagawa, MD; Masato Shibamoto, MD; Taku Sakai, MD; Akihito Hashimoto, MD; Yuki Kuramoto, MD; Tomokazu Sumida, MD, PhD; Seitaro Nomura, MD, PhD; Masamichi Ito, MD; Toshihiro Yamaguchi, MD; Toru Oka, MD, PhD; Hiroshi Akazawa, MD, PhD; Jong-Kook Lee, MD, PhD; Sachio Morimoto, PhD; Yasushi Sakata, MD, PhD; Ichiro Shiojima, MD, PhD; Issei Komuro, MD, PhD such as cell proliferation, stress tolerance, and metabolism. 6 FoxO factors have also been reported to regulate skeletal muscle wasting and fiber type specification. 7, 8 FoxO overexpression in skeletal muscle promotes muscle atrophy and fiber type shift from type I to type II fiber. 9 In contrast, overexpression of either peroxisome proliferator-activated receptor γ coactivator 1α or insulin-like growth factor 1 in skeletal muscle ameliorates skeletal myopathy in heart failure through suppression of FoxO activity. 10, 11 These studies suggest that FoxO signaling is critically involved in skeletal myopathy associated with CHF, however, it remains elusive how FoxO signaling is activated in patients with CHF. Wnt signaling is an evolutionarily conserved signaling cascade that plays essential roles in embryonic development through regulating various cellular processes, including cell differentiation and proliferation. 12, 13 Recent studies have reported that Wnt signaling also plays an important role during adulthood, including stem cell regulation, skeletal muscle regeneration, and cancer progression. 14, 15 β-catenin is the key protein that mediates Wnt signal transduction. In the absence of activation of Wnt receptors, cytosolic β-catenin is usually degraded via proteasome system. However, when Wnt receptors are activated, cytosolic β-catenin becomes stabilized and translocates into the nucleus where it usually binds with T-cell factor (TCF) or lymphoid enhancer factor (LEF) transcription factors and induces Wnt/β-catenin/ TCF/LEF target gene transcription. 13 Essers et al 16 reported that β-catenin also binds to FoxO transcription factors and induces the expression of FoxO target genes. Interaction between Wnt signaling and FoxO signaling is also observed in vivo and plays an important role in the pathophysiology of diabetes mellitus, cancer metastasis, and bone formation. [17] [18] [19] We have recently reported that serum from CHF model mice activates Wnt signaling more potently than serum from control mice and that complement C1q mediates this activation. 20 Here, we demonstrate that activation of Wnt signaling plays a causative role in fiber type shift in skeletal myopathy associated with CHF through functional interaction between FoxO and β-catenin.
Methods
An expanded Methods section is available in the Data Supplement.
Animal Model
All experiments were approved by the Institutional Animal Care and Use Committee of Osaka University. We used knock-in mice with deletion mutation K210 in cardiac troponin T gene as dilated cardiomyopathy (DCM) model mice. 21 
Cell Culture
C2C12 mouse myoblasts were maintained in growth medium (DMEM supplemented with 20% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin). For myotube formation, growth medium was replaced with differentiation medium (DMEM supplemented with 2% horse serum, 100 U/mL penicillin, and 100 μg/mL streptomycin). Plasmid DNA transfection was performed using Lipofectamine 2000 (Invitrogen). siRNAs were transfected at a concentration of 200 nmol/L using Lipofectamine RNAiMAX (Invitrogen).
Statistical Analysis
All values are reported as mean±SD. Statistical analyses were performed with JMP Pro 10.0.2 (SAS Institute Inc). We analyzed the data using Wilcoxon rank sum test to compare 2 groups. For comparing ≥3 groups, we used the Kruskal-Wallis procedure followed by Steel-Dwass multiple comparisons test. Significant differences were defined as P<0.05.
Results

Skeletal Muscle Fiber Type Shift in Heart Failure Model Mice
We used DCM model mice with knock-in mutation containing deletion of K210 in cardiac troponin T as a model of CHF. 21 These DCM mice exhibited heart failure with marked left ventricular dysfunction and increased heart weight and lung weight at the age of 2 months ( Figure 1A and 1B) . Weight of the skeletal muscle was not decreased in these mice ( Figure 1C ). However, the expression of Myh7 and Myh2, which encode the myosin heavy chain gene for type I and type IIa fatigue-resistant fiber, was markedly decreased, whereas the expression of Myh4, which encodes the myosin heavy chain gene for type IIb fatigable fiber, was increased in the quadriceps muscle, a typical muscle, which is mainly consisted with type II fiber ( Figure 1D ). Decreased expression of Myh7 and increased expression of Myh4 was also observed in the soleus muscle, a typical muscle, which is mainly consisted with type I fiber ( Figure 1D ). Immunostaining revealed that loss of type IIa fiber in the quadriceps muscle and appearance of type IIb fiber in the soleus muscle were observed in DCM mice ( Figure 1E ). These results collectively suggest that the early stage skeletal myopathy characterized by fiber type shift toward fatigable fiber is observed in DCM mice.
FoxO Signaling and Wnt Signaling are Both Activated in Skeletal Muscle of DCM Mice
Activation of FoxO signaling is known to play a causative role in skeletal muscle atrophy. 9 We found that the expression of FoxO target genes and the nuclear amount of FoxO1 were increased in the skeletal muscle of DCM mice (Figure 2A and 2B). The purity of the nuclear fraction in the skeletal muscle was confirmed by Western blot analysis ( Figure IA in the Data Supplement). FoxO activity is mainly regulated by its subcellular localization and phosphorylation of FoxO by Akt and other kinases regulates its nuclear translocation. 6 However, the phosphorylation levels of FoxO1 in skeletal muscle were comparable between DCM mice and wild-type mice ( Figure 2B ), and similar changes in localization and phosphorylation were also observed in FoxO3a ( Figure IB Wnt signaling has also been implicated in the development of muscle atrophy. 22 We found that the expression of a Wnt/β-catenin/TCF/LEF target gene Axin2 and the nuclear amount of β-catenin were increased in the skeletal muscle of DCM mice ( Figure 2C and 2D), suggesting that Wnt signaling as well as FoxO signaling is activated in the skeletal muscle of DCM mice.
Functional Interaction Between β-Catenin and FoxO in Cultured Skeletal Myocytes
A previous report suggests that the direct interaction of β-catenin and FoxO prompts FoxO activation downstream of Wnt signaling. 16 Among FoxO subfamily members, FoxO1 plays a major role in the regulation of skeletal muscle fiber type. 8, 9 We, therefore, tested whether activation of Wnt signaling promotes the binding between β-catenin and FoxO1 and cross-activates FoxO-dependent gene transcription in skeletal muscle. Wnt3a treatment promoted the binding of FoxO1 and β-catenin and increased the level of nuclear localized FoxO1 in C2C12 cells overexpressing wild-type FoxO1 ( Figure IIA in the Data Supplement). 16, 23 Expression of FoxO target genes as well as a Wnt/β-catenin/TCF/LEF target gene Axin2 was increased by Wnt3a treatment in C2C12 cells overexpressing wild-type FoxO1 and these changes were blocked by Dkk1 ( Figure 3C , left), whereas the expression of Axin2 but not FoxO target genes was increased by Wnt3a treatment in C2C12 cells 
Wnt Signaling Promotes Fiber Type Shift Through Transactivation of FoxO Signaling
We next assessed whether Wnt signaling and FoxO signaling affect the fiber type of skeletal muscle using C2C12 cells. Activation of Wnt signaling by Wnt3a increased the expression of Myh1 and Myh4 and decreased the expression of Myh2, suggesting that Wnt signaling affects the fiber type of skeletal muscle at the cellular level ( Figure 4A ). We next tested how the interaction between Wnt signaling and FoxO signaling acts on the fiber type shift of skeletal muscle. We established inducible C2C12 cell lines that harbor cumate-inducible wildtype FoxO1, dominant negative FoxO1, or constitutively active FoxO1 and differentiated them into myotubes with or without Wnt3a. We found that Wnt3a treatment increased the expression of Myh1 and Myh4 and decreased the expression of Myh7 in myotubes overexpressing wild-type FoxO1, which was reversed by addition of Dkk1 ( Figure 4B Mef2c. 8, 9 Overexpression of constitutively active FoxO1 suppressed the expression of Mef2c, whereas knockdown of FoxO1 enhanced the expression of Mef2c (Figure IIIC and IIIE in the Data Supplement). These results suggest that Wnt signaling affects the fiber type shift from fatigue-resistant fiber to fatigable fiber by coactivation of FoxO signaling.
Increased Serum Wnt Activity in DCM Mice Induces Fiber Type Shift Toward Fatigable Fiber
We have recently reported that serum from heart failure model mice activates Wnt signaling more potently than the serum from wild-type mice and that complement C1q is responsible for its activity. 20 As expected, serum from DCM mice increased the level of nuclear β-catenin and the expression of Axin2 in C2C12 cells compared with the serum from wild-type mice ( Figure 5A and 5B). The serum from DCM mice also increased the level of nuclear FoxO1 and the expression of FoxO target genes and promoted the fiber type shift toward fatigable fiber ( Figure 5A and 5B). All these changes were blocked by treatment with Dkk1 ( Figure 5A and 5B ). Phosphorylation of FoxO1 and Akt was not affected by the serum from DCM mice ( Figure 5A ). We also found that intramuscular injection of Dkk1 blocked the activation of FoxO signaling and the fiber type shift toward fatigable fiber in the skeletal muscle of DCM mice (Figure 5C ). These results suggest that activation of Wnt signaling by substances in the serum plays a causative role in the activation of FoxO signaling and fiber type shift in the skeletal muscle of DCM mice.
Complement C1q Mediates Serum-Induced Activation of Wnt Signaling in DCM Mice
Given that complement C1q is at least one of the substances in the serum that activate Wnt signaling, 20 we tested whether C1q is responsible for fiber type shift in DCM mice. ELISA analysis revealed that serum C1q concentration was increased in the serum from DCM mice ( Figure 6A ). Stimulation with C1q increased the expression of Myh1 and Myh4 as well as FoxO target genes in myotubes ( Figure 6B ), whereas C1-inhibitor, an endogenous inhibitor of C1r and C1s, blocked the effect of the serum from DCM mice ( Figure 6C ). We also found that intravenous injection of C1-inhibitor blocked the activation of both Wnt signaling and FoxO signaling and prevented the fiber type shift toward fatigable fiber in the skeletal muscle of DCM mice ( Figure 6D ). These results suggest that increased C1q in the serum activates FoxO signaling and plays a causative role in fiber type shift toward fatigable fiber in DCM mice.
Discussion
In this study, we found that activation of Wnt signaling and functional interaction between β-catenin and FoxO play a critical role in the development of skeletal myopathy associated with CHF. We showed that activation of Wnt signaling in skeletal muscle induces nuclear translocation of FoxO transcription factors and promotes fiber type shift from fatigue-resistant fiber to fatigable fiber. We also elucidated that C1q increased in the serum of heart failure model mice might play a causative role in the fiber type shift toward fatigable fiber by activating both Wnt and FoxO signaling. Our findings suggest the novel molecular mechanisms underlying the regulation of fiber type shift during CHF. Because fiber type shift of the skeletal muscle is one of the most important qualitative changes during progression of skeletal myopathy in patients with CHF, our findings may lead to the development of new therapeutic strategies targeting skeletal myopathy that would eventually improve the daily activities and quality of life in patients with CHF.
In patients with CHF, skeletal myopathy is frequently observed and recognized as a major cause of exercise intolerance. 5, 25 Muscle wasting is one of the major abnormalities in skeletal myopathy associated with CHF. 1 However, we did not observe skeletal muscle wasting in this study, in part because of the differences in the animal models. 10, 26 The fiber type shift toward fatigable fiber is another major abnormality in CHF-associated skeletal myopathy and accounts for the exercise intolerance in patients with CHF. 2, 5 Our observations suggest that CHF-associated fiber type shift of the skeletal muscle might occur independently of or earlier than muscle wasting.
FoxO transcription factors are highly conserved in evolution and play important roles in various cellular processes, including skeletal muscle homeostasis and fiber type specification. 6, 27 Recent studies have revealed its contribution during skeletal myopathy associated with CHF. 10, 11 FoxO activity is mainly controlled by its subcellular localization. Phosphorylation of FoxO is the most widely known mechanism that controls the localization of FoxO protein. 6 However, recent studies revealed that FoxO activity is also regulated by other mechanisms, including its interaction with β-catenin. 6, 16 Wnt signaling is also an evolutionarily conserved signaling cascade, which plays essential roles during embryonic development. 13 Recent studies have indicated that Wnt signaling also plays an important role in skeletal muscle atrophy and regeneration. 14, 22 In this study, we have demonstrated that both Wnt signaling and FoxO signaling are activated in skeletal muscle of DCM mice. We have also shown that Wnt signaling promotes FoxO1 nuclear translocation without affecting its phosphorylation level and increases the expression of FoxO target genes in cultured skeletal muscle cells. A recent report showed that interaction between Wnt signaling and FoxO signaling in hepatocytes plays an important role in regulating hepatic metabolism. 17 In this study, we have identified another role of Wnt-FoxO interaction in regulating the homeostasis of skeletal muscle fiber.
We have recently reported that serum from heart failure model mice activates Wnt signaling more potently than serum from control mice and that complement C1q mediates this activation. 20 In this study, we have demonstrated that increased C1q in the serum from DCM mice activates Nuclear protein and total protein were extracted from C2C12 cells and the expression of β-catenin, FoxO1, phosphorylated FoxO1, Akt, and phosphorylated Akt was analyzed by Western blotting and quantified by densitometry analysis. Histone H3 and GAPDH were used as internal controls for nuclear protein and total protein, respectively (n=5 each). *P<0.05 between groups. B, C2C12 cells were treated as indicated in (A). Expression of fiber type-specific myosin heavy chain genes, a Wnt/βcatenin/T-cell factor (TCF)/lymphoid enhancer factor (LEF) target gene Axin2 and FoxO target genes was analyzed by quantitative reverse transcription polymerase chain reaction (RT-PCR; n=8 each). *P<0.05 between groups. C, Dkk1 (500 ng in 25 μL solution) or equal amount of control solution (0.1% BSA/PBS) was injected into tibialis anterior muscles. Tibialis anterior muscles were harvested 2 days after injection. Expression of fiber type-specific myosin heavy chain genes, a Wnt/β-catenin/ TCF/LEF target gene Axin2 and FoxO target genes in tibialis anterior muscles was analyzed by quantitative RT-PCR (n=8 each). *P<0.05 between groups.
FoxO signaling through activation of Wnt signaling in skeletal muscle cells. C1q is known to be produced from the cells of a monocyte/macrophage lineage and upregulation of C1q biosynthesis leads to an increase in serum C1q concentration in aged mice. 20, 28 Although we do not know the mechanism by which C1q level is increased in the serum of DCM mice, we speculate that it reflects the chronic inflammation observed in patients with CHF or in animal models of CHF. 29 Overexpression of constitutively active β-catenin has been reported to promote the fiber type shift toward type I fatigue-resistant fiber. 30 Then why the activation of Wnt signaling changed the fiber type from type I to type II in the skeletal muscle of DCM mice? It has been proposed that TCF/LEF and FoxO transcription factors compete for the limited pool of active β-catenin, 31 and that β-catenin is diverted from TCF/LEF to FoxO under certain conditions, such as nutritional starvation and oxidative stress. 16, 17, 31 Oxidative stress promotes the use of active β-catenin by FoxO and increases the expression of FoxO target genes, whereas it suppresses the use of active β-catenin by TCF/ LEF and decreases expression of Wnt/β-catenin/TCF/LEF target genes. 31 It has been reported that oxidative stress plays an important role in the pathogenesis of CHF and that oxidative stress is increased in the skeletal muscle as well as in the heart during CHF. 32, 33 Activation of Wnt signaling in the skeletal muscle of DCM mice may be somewhat modified by increased oxidative stress; oxidative stress may promote use of β-catenin by FoxO that promotes the expression of type II fatigable fiber at the expense of TCF/LEF-mediated classical Wnt signaling that promotes the expression of type I fatigue-resistant fiber (Figure 7) . 9 Figure 6 . Serum C1q activates Wnt signaling and forkhead box O (FoxO) signaling and induces fiber type shift in vitro and in vivo. A, Concentration of C1q in the serum of wild-type (WT) and dilated cardiomyopathy (DCM) mice was assessed by ELISA (n=12 each). *P<0.05 vs WT mice. B, C2C12 cells were stimulated with C1q (100 μg/mL) from day 6 to day 8 of differentiation. Expression of fiber type-specific myosin heavy chain genes, a Wnt/β-catenin/ T-cell factor (TCF)/lymphoid enhancer factor (LEF) target gene Axin2 and FoxO target genes in C2C12 cells was analyzed by quantitative reverse transcription polymerase chain reaction (RT-PCR; n=8 each). †P<0.05 vs control. C, C2C12 cells were treated with serum from WT mice (10% final concentration), serum from DCM mice (10% final concentration), or serum from DCM mice plus C1-inhibitor (C1-INH, 100 μg/mL) from day 6 to day 8 of differentiation. Expression of fiber type-specific myosin heavy chain genes, a Wnt/β-catenin/TCF/LEF target gene Axin2 and FoxO target genes in C2C12 cells was analyzed by quantitative RT-PCR (n=8 each). ‡P<0.05 between groups. D, C1-INH (15U in 150 μL solution) or equal amount of PBS (as a control) was administered intravenously. Tibialis anterior muscles were harvested 2 days after administration. Expression of fiber type-specific myosin heavy chain genes, a Wnt/β-catenin/TCF/LEF target gene Axin2, and FoxO target genes in tibialis anterior muscles was analyzed by quantitative RT-PCR (WT, n=6; DCM, n=4; and DCM+C1-INH; n=6). ‡P<0.05 between groups. 
